JPWO2020074459A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020074459A5 JPWO2020074459A5 JP2021518891A JP2021518891A JPWO2020074459A5 JP WO2020074459 A5 JPWO2020074459 A5 JP WO2020074459A5 JP 2021518891 A JP2021518891 A JP 2021518891A JP 2021518891 A JP2021518891 A JP 2021518891A JP WO2020074459 A5 JPWO2020074459 A5 JP WO2020074459A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody fragment
- human
- domain
- met antibody
- amino acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102018000009282 | 2018-10-09 | ||
| IT102018000009282A IT201800009282A1 (it) | 2018-10-09 | 2018-10-09 | Nuovo agente terapeutico per il trattamento di un tumore e/o metastasi |
| PCT/EP2019/077116 WO2020074459A1 (en) | 2018-10-09 | 2019-10-07 | Anti-met fab-fc for the treatment of a tumor and/or metastasis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022504392A JP2022504392A (ja) | 2022-01-13 |
| JPWO2020074459A5 true JPWO2020074459A5 (da) | 2022-05-12 |
| JP7371093B2 JP7371093B2 (ja) | 2023-10-30 |
Family
ID=65010823
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021518891A Active JP7371093B2 (ja) | 2018-10-09 | 2019-10-07 | 腫瘍および／または転移の治療のための抗－ｍｅｔ ｆａｂ－ｆｃ |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20210395372A1 (da) |
| EP (2) | EP3864050B1 (da) |
| JP (1) | JP7371093B2 (da) |
| KR (1) | KR20210075121A (da) |
| CN (1) | CN113330032A (da) |
| AU (1) | AU2019358417A1 (da) |
| CA (1) | CA3115582A1 (da) |
| DK (1) | DK3864050T3 (da) |
| ES (1) | ES2938714T3 (da) |
| FI (1) | FI3864050T3 (da) |
| HR (1) | HRP20230154T1 (da) |
| HU (1) | HUE060843T2 (da) |
| IL (1) | IL282033A (da) |
| IT (1) | IT201800009282A1 (da) |
| LT (1) | LT3864050T (da) |
| PL (1) | PL3864050T3 (da) |
| PT (1) | PT3864050T (da) |
| RS (1) | RS63960B1 (da) |
| SG (1) | SG11202103575RA (da) |
| SI (1) | SI3864050T1 (da) |
| WO (1) | WO2020074459A1 (da) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1718677E (pt) * | 2003-12-19 | 2012-07-18 | Genentech Inc | Fragmentos de anticorpo monovalentes úteis como agentes terapêuticos |
| KR101429297B1 (ko) | 2006-02-06 | 2014-08-12 | 메테레시스 트랜스레이셔날 리서치 에스.에이. | 종양 치료를 위한 항-Ｍｅｔ 단클론 항체, 이의 단편과벡터 및 상응하는 산물 |
| PL2013236T3 (pl) * | 2006-04-28 | 2015-12-31 | Delenex Therapeutics Ag | Przeciwciała łączące się z zewnątrzkomórkową domeną receptora kinazy tyrozynowej ALK |
| CN106432503B (zh) * | 2008-12-19 | 2020-03-06 | 宏观基因有限公司 | 共价双抗体及其用途 |
| CA2756988A1 (en) * | 2009-04-01 | 2010-10-07 | Genentech, Inc. | Anti-fcrh5 antibodies and immunoconjugates |
| US9074000B2 (en) * | 2011-04-01 | 2015-07-07 | Memorial Sloan Kettering Cancer Center | T cell receptor-like antibodies specific for a WT1 peptide presented by HLA-A2 |
| EP2748197A2 (en) * | 2011-08-26 | 2014-07-02 | Merrimack Pharmaceuticals, Inc. | Tandem fc bispecific antibodies |
| CN104066748A (zh) | 2011-11-21 | 2014-09-24 | 霍夫曼-拉罗奇有限公司 | 抗c-met抗体的纯化 |
| ITTO20130012A1 (it) | 2013-01-09 | 2014-07-10 | Metheresis Translational Res S A | Nuovi frammenti anticorpali, relative composizioni ed usi |
| GB201403875D0 (en) * | 2014-03-05 | 2014-04-16 | Cantargia Ab | Novel antibodies and uses thereof |
-
2018
- 2018-10-09 IT IT102018000009282A patent/IT201800009282A1/it unknown
-
2019
- 2019-10-07 RS RS20230107A patent/RS63960B1/sr unknown
- 2019-10-07 EP EP19808675.3A patent/EP3864050B1/en active Active
- 2019-10-07 SI SI201930456T patent/SI3864050T1/sl unknown
- 2019-10-07 HU HUE19808675A patent/HUE060843T2/hu unknown
- 2019-10-07 EP EP22206743.1A patent/EP4194469A1/en active Pending
- 2019-10-07 PL PL19808675.3T patent/PL3864050T3/pl unknown
- 2019-10-07 PT PT198086753T patent/PT3864050T/pt unknown
- 2019-10-07 CN CN201980080611.2A patent/CN113330032A/zh active Pending
- 2019-10-07 LT LTEPPCT/EP2019/077116T patent/LT3864050T/lt unknown
- 2019-10-07 DK DK19808675.3T patent/DK3864050T3/da active
- 2019-10-07 HR HRP20230154TT patent/HRP20230154T1/hr unknown
- 2019-10-07 CA CA3115582A patent/CA3115582A1/en active Pending
- 2019-10-07 JP JP2021518891A patent/JP7371093B2/ja active Active
- 2019-10-07 US US17/283,482 patent/US20210395372A1/en active Pending
- 2019-10-07 ES ES19808675T patent/ES2938714T3/es active Active
- 2019-10-07 KR KR1020217013513A patent/KR20210075121A/ko unknown
- 2019-10-07 FI FIEP19808675.3T patent/FI3864050T3/fi active
- 2019-10-07 AU AU2019358417A patent/AU2019358417A1/en active Pending
- 2019-10-07 WO PCT/EP2019/077116 patent/WO2020074459A1/en unknown
- 2019-10-07 SG SG11202103575RA patent/SG11202103575RA/en unknown
-
2021
- 2021-04-04 IL IL282033A patent/IL282033A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2022218544A1 (en) | Hetero-dimeric multi-specific antibody format | |
| KR101522954B1 (ko) | 항체 중쇄불변부위의 이종이중체 고효율 형성을 유도하는 ch3 도메인 변이체 쌍, 이의 제조방법, 및 용도 | |
| EP3144320B9 (en) | Fc fusion proteins comprising novel linkers or arrangements | |
| JP2012515556A5 (da) | ||
| US20230192887A1 (en) | Engineered anti-her2 bispecific proteins | |
| JPWO2020074459A5 (da) | ||
| WO2019122409A1 (en) | Bispecific antigen binding construct | |
| US8207307B2 (en) | Antibodies against human CCN1 and uses thereof | |
| FI3864050T3 (fi) | Anti-met-fab-fc kasvaimen ja/tai metastaasin hoitamiseksi | |
| WO2023174238A1 (zh) | 特异性结合gprc5d和cd3的抗原结合分子及其医药用途 | |
| WO2024046301A1 (zh) | 包含taci多肽的融合蛋白及其用途 | |
| CN118119402A (zh) | 工程化抗her2双特异性蛋白 | |
| WO2022237882A1 (zh) | 一种抗原结合分子 | |
| WO2024131711A1 (zh) | NKp46抗体及其用途 | |
| WO2023186120A1 (zh) | 抗血清白蛋白纳米抗体及其衍生物 | |
| US20230391892A1 (en) | Bifunctional antagonists of tumor necrosis factor alpha and transforming growth factor beta and uses thereof | |
| CN117916259A (zh) | 特异性结合cgrp和pacap的抗原结合分子及其医药用途 | |
| WO2023208182A1 (zh) | 抗ccr8抗体及其用途 | |
| TW202328186A (zh) | 抗ｈｅｒ２抗體及其使用方法 | |
| CA3237992A1 (en) | Truncated taci polypeptide and fusion protein and use thereof |